BackgroundAedes aegypti is a container-inhabiting mosquito and a vector of dengue, chikungunya, and Zika viruses. In 2009 several cases of autochthonous dengue transmission were reported in Key West, Florida, USA prompting a comprehensive response to control A. aegypti. In Key West, larvae of this mosquito develop in containers around human habitations which can be numerous and labor intensive to find and treat. Aerial applications of larvicide covering large areas in a short time can be an efficient and economical method to control A. aegypti. Bacillus thuringiensis israelensis (Bti) is a bacterial larvicide which is highly target specific and appropriate for wide area spraying over urban areas, but to date, there are no studies that evaluate aerial spraying of Bti to control container mosquitoes like A. aegypti.MethodologyThis paper examines the effectiveness of aerial larvicide applications using VectoBac® WG, a commercially available Bti formulation, for A. aegypti control in an urban setting in the USA. Droplet characteristics and spray drop deposition were evaluated in Key West, Florida, USA. The mortality of A. aegypti in containers placed under canopy in an urban environment was also evaluated. Efficacy of multiple larvicide applications on adult female A. aegypti population reduction was compared between an untreated control and treatment site.ConclusionsDroplet characteristics showed that small droplets can penetrate through dense canopy to reach small containers. VectoBac WG droplets reached small containers under heavy canopy in sufficient amounts to cause > 55% mortality on all application days and >90% mortality on 3 of 5 application days while controls had <5% mortality. Aerial applications of VectoBac WG caused significant decrease in adult female populations throughout the summer and during the 38th week (last application) the difference in adult female numbers between untreated and treated sites was >50%. Aerial larvicide applications using VectoBac WG can cover wide areas in a short period of time and can be effective in controlling A. aegypti and reducing A. aegypti-borne transmission in urban areas similar to Key West, Florida, USA.
The presence of Aedes albopictus (Skuse) was first reported in the Florida Keys in 1993. Despite extensive surveillance, the Florida Keys Mosquito Control District (FKMCD) only collected specimens occasionally on a few islands, some years finding no evidence of the invasive species. In 2013-2017, FKMCD witnessed a sudden increase in population size and geographic extent of Ae. albopictus. Samples of Ae. albopictus have now been identified on 30 different islands in the Florida Keys. Three islands in particular (Key Largo, Big Pine Key, and Stock Island) have produced multiple positive samples during at least 4 of the last 5 yr, suggesting establishment of the invasive species. FKMCD continues to monitor Ae. albopictus throughout the Keys and make extensive efforts to reduce population abundance and geographic extent of this disease vector.
Aedes aegypti L. is considered to have a proclivity for feeding on human blood even when other hosts are available. However, few studies have demonstrated host use by this mosquito in the continental United States, where local transmission of dengue, Zika, and chikungunya viruses has been recently documented. This study investigated the bloodmeal sources of female Ae. aegypti in the subtropical city of Key West and the surrounding county in Florida with the goal of identifying preferred hosts. Blood-engorged Ae. aegypti mosquitoes were collected from BG Sentinel traps used as part of a routine surveillance program in the Florida Keys (Monroe County, Florida). Bloodmeal samples were analyzed using PCR assays, sequencing, and comparison with reference sequences in GenBank. Aedes aegypti females from Key West fed predominantly on humans (79.6%) and did not differ statistically from females collected from the rest of the Florida Keys (69.5%). Culex quinquefasciatus Say (Diptera: Culicidae), considered a host generalist, was collected and analyzed from the same sites for comparative purposes. Females of Cx. quinquefasciatus fed predominantly (70.7%) on birds and nonhuman mammals in the Florida Keys, corroborating the validity of molecular assay breadth and demonstrating that given the same group of available hosts Ae. aegypti selects humans. Our results indicated that Ae. aegypti has a high rate of human-biting in a subtropical area within the United States, supporting its role in recent local transmission of dengue and other viruses.
Mosquito control programs in the State of Florida are charged with protecting human and animal health, fostering economic development of the State, permitting enjoyment of the natural attractions in Florida, and improving the quality of life of citizens. Mosquito control programs must accomplish these tasks in such a manner as will protect the environment and terrestrial, marine, and freshwater ecosystems. The Florida Keys Mosquito Control District provides a science-based Integrated Pest Management mosquito control program to the residents of the Florida Keys, Monroe County, Florida. Operational decisions are based on surveillance of adult and immature mosquitoes. Mosquito populations are monitored by means of carbon dioxide-baited light traps BG Sentinel traps, truck traps, gravid traps, oviposition traps, and human landing rate counts. Larvae and pupae are monitored by inspections of natural and human-made immature habitats. Due to past and current reliance on chemical pesticides for control of mosquitoes, the District maintains a pesticide resistance detection program consisting of CDC bottle bioassays and larval bioassays, challenging local mosquito species with currently used adulticides and larvicides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.